Hysterectomy is the most commonly performed major gynecologic surgery in the United States. Over 400,000 hysterectomies are performed annually in the United States and it is estimated that 1 in 3 women will have had a hysterectomy by age 60 years. Of the benign hysterectomies performed in the United States, 68% are done for the primary indication of abnormal uterine bleeding (AUB), uterine leiomyomata, and endometriosis. The American Congress of Obstetricians and Gynecologists (ACOG) supports the use of alternatives to hysterectomy.
Over the past decade, there has been a substantial decline in the number of hysterectomies performed annually in the United States. Wright et al analyzed annual inpatient hysterectomy rates in the United States and found a 36.4% decrease in number of hysterectomies performed in 2010 (433,621) as compared to 2002 (681,234). One explanation for these results is an increase in utilization of uterine-sparing alternatives to hysterectomy. However, despite the decrease in numbers of hysterectomies in the United States, appropriateness of hysterectomy is still an area of concern. In 1 study of 497 hysterectomies in California, 76% of those done for endometriosis, AUB or chronic pelvic pain failed to meet ACOG criteria.
Read more by clicking below:
NAFDAC Partners Nollywood On Fibroid Treatment
The National Agency for Food Drug Administration and Control (NAFDAC) is partnering with Nollywood actress, Monalisa Chinda, to treat ten women of uterine fibroid disease across the country.
At the inauguration of the project in Abuja today, Monalisa Chinda under her Arise Monalisa Foundation, said “this is a cause that is very close to my heart because at every stage you get in life, you just want to give back to the society.”
Click here to read more about fibroid awareness worldwide!
Since the 1990s, thousands of women have undertaken a surgical procedure that may have risked their lives. After Dr. Amy Reed had surgery to remove uterine fibroids, involving a procedure known as power morcellation, she learned that it had worsened her prognosis by spreading a cancer she and her doctors didn’t know she had. Dr. Reed became a vocal critic of power morcellators and the doctors who used them, dividing the medical community. Now doctors and companies are waiting for more-permanent guidance from the FDA. This story, drawn from ongoing coverage in The Wall Street Journal, is a gripping human-interest account of public trust and the fallibility of modern medicine.
Register for FREE at The Wall Street Journal to read the full eBook.
Deadly Medicine: A Common Surgery for Women and the Cancer It Leaves Behind